Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Trinean to Appoint New Board Member

Published: Friday, May 02, 2014
Last Updated: Friday, May 02, 2014
Bookmark and Share
Company announced that it appointed Mr Chris van Ingen as independent board member.

“We are very pleased to be working with Chris van Ingen,” comments Philippe Stas, CEO of Trinean. "His broad experience in the life science instrumentation field will be valuable to bring Trinean in its next phase of expansion.” 

“Trinean’s fully integrated instrumentation platform offers excellent opportunities to automate and simplify many life sciences workflows”, Chris van Ingen adds, “and I am looking forward working with the Trinean board and management team.” 

Currently, Chris is a director of the Bruker corporation, the Promega corporation and ProteinSimple corporation. Previously, Mr. van Ingen was president of Agilent Technologies’ Bio-Analytical Measurement Group. Between 1977 and 2001, Mr. van Ingen held several senior management positions at Hewlett Packard, including Vice President of Sales and Marketing of the Chemical Analysis group.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

EMQN Integrates Trinean’s DropSense™ Into Its Standards Qc Procedures and Quality Assessment Schemes
Company has announced that the DropSense™96 has been integrated by EMQN as the standard QC tool for DNA samples used in its External Quality Assessment (EQA) schemes for molecular genetic labs.
Wednesday, February 17, 2016
Trinean to be Awarded ISO 9001:2008 Certification
Certification awarded for Trinean’s Quality Management System.
Tuesday, February 03, 2015
Trinean to Enter into Global Supply Agreement with QIAGEN
Trinean to manufacture and supply the QIAxpert - a micro-volume spectrometer for DNA and RNA quantitation and quality analysis.
Tuesday, January 21, 2014
Trinean Signs a Global Agreement with Bayer CropScience
Bayer will use Trinean’s technology for biomolecule QC using spectral content profiling.
Wednesday, June 12, 2013
Trinean Secures 1 Million Euro Financing
Capricorn Health-tech Fund to join the investor base.
Wednesday, May 29, 2013
Trinean Appoints New CEO and Secures 2.7 Million Euro Financing
Appointment of Philippe Stas as Company’s new CEO.
Monday, April 30, 2012
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!